Accelerating phase III clinical trial enrollment

A pharmaceutical company was struggling with slow phase III patient recruitment, achieving only "20% patient enrollment within the 24-month goal provided by the FDA," because selected trial sites had too few eligible patients and investigators were enrolling slowly. It used Definitive Healthcare's clinical trial accelerator tool to analyze claims data, which revealed that "eighteen of the top twenty sites with eligible patients were not part of the clinical trial," and generated a dynamic list of high-performing investigators, sites, and referring physicians. The company completed enrollment of the remaining 80% of patients within 12 months, achieved "$10M in clinical trial cost savings," and received FDA approval "12 months earlier than anticipated."

The customer is anonymised in Definitive Healthcare’s own case study — not withheld by us.

Definitive Healthcare is a claims and provider-reference data platform used by pharma commercial teams for go-to-market planning and sales targeting.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.